BioPharma Credit PLC Performance
| BOPCFDelisted Stock | USD 0.92 0.00 0.00% |
BioPharma Credit has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.17, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning BioPharma Credit are expected to decrease at a much lower rate. During the bear market, BioPharma Credit is likely to outperform the market. BioPharma Credit PLC right now shows a risk of 1.56%. Please confirm BioPharma Credit PLC maximum drawdown, as well as the relationship between the skewness and day median price , to decide if BioPharma Credit PLC will be following its price patterns.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in BioPharma Credit PLC are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable fundamental indicators, BioPharma Credit is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
BioPharma |
BioPharma Credit Relative Risk vs. Return Landscape
If you would invest 91.00 in BioPharma Credit PLC on October 5, 2025 and sell it today you would earn a total of 1.00 from holding BioPharma Credit PLC or generate 1.1% return on investment over 90 days. BioPharma Credit PLC is currently producing 0.0591% returns and takes up 1.5599% volatility of returns over 90 trading days. Put another way, 14% of traded pink sheets are less volatile than BioPharma, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
BioPharma Credit Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioPharma Credit's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as BioPharma Credit PLC, and traders can use it to determine the average amount a BioPharma Credit's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0379
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | BOPCF | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average BioPharma Credit is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioPharma Credit by adding it to a well-diversified portfolio.
BioPharma Credit Fundamentals Growth
BioPharma Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of BioPharma Credit, and BioPharma Credit fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioPharma Pink Sheet performance.
| Return On Equity | 0.079 | |||
| Return On Asset | 0.0493 | |||
| Profit Margin | 0.85 % | |||
| Operating Margin | 0.85 % | |||
| Current Valuation | 1.22 B | |||
| Shares Outstanding | 914.25 M | |||
| Price To Earning | 13.38 X | |||
| Price To Sales | 10.63 X | |||
| Revenue | 127.83 M | |||
| Cash And Equivalents | 10.44 M | |||
| Cash Per Share | 0.01 X | |||
| Book Value Per Share | 1.01 X | |||
| Cash Flow From Operations | 96.44 M | |||
| Earnings Per Share | 0.06 X | |||
About BioPharma Credit Performance
By analyzing BioPharma Credit's fundamental ratios, stakeholders can gain valuable insights into BioPharma Credit's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BioPharma Credit has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BioPharma Credit has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. The company was incorporated in 2016 and is based in Exeter, the United Kingdom. Biopharma Credit is traded on OTC Exchange in the United States.Things to note about BioPharma Credit PLC performance evaluation
Checking the ongoing alerts about BioPharma Credit for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for BioPharma Credit PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BioPharma Credit PLC is not yet fully synchronised with the market data | |
| BioPharma Credit PLC has some characteristics of a very speculative penny stock | |
| BioPharma Credit PLC has a very high chance of going through financial distress in the upcoming years |
- Analyzing BioPharma Credit's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioPharma Credit's stock is overvalued or undervalued compared to its peers.
- Examining BioPharma Credit's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioPharma Credit's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioPharma Credit's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BioPharma Credit's pink sheet. These opinions can provide insight into BioPharma Credit's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in BioPharma Pink Sheet
If you are still planning to invest in BioPharma Credit PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioPharma Credit's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |